The McLean Hospital Corporation
Personalizing Self Neuro-Modulation Therapy for Major Depressive Disorder (MDD) using Clinical Biomarkers for MDD Subtypes — US partner. Israeli partner: GrayMatters Health Ltd. (Haifa (Haifa & North)). Sector: Life Sciences, Medical Devices.